ArticleJournal of cancer research and clinical oncology2015

Genetic polymorphisms of phase I and phase II metabolic enzymes as modulators of lung cancer susceptibility.

P Mota et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.